# Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

> **NCT00488514** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 656 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Combination Tablet of Treximet (sumatriptan/naproxen sodium)

## Key facts

- **NCT ID:** NCT00488514
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07-13
- **Primary completion:** 2009-08-01
- **Final completion:** 2009-08-20
- **Target enrollment:** 656 (ACTUAL)
- **Last updated:** 2017-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00488514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00488514, "Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00488514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*